RT Journal Article
SR Electronic
T1 Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of Gliomas
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 1293
OP 1298
VO 45
IS 8
A1 Benoit Pirotte
A1 Serge Goldman
A1 Nicolas Massager
A1 Philippe David
A1 David Wikler
A1 Arlette Vandesteene
A1 Isabelle Salmon
A1 Jacques Brotchi
A1 Marc Levivier
YR 2004
UL http://jnm.snmjournals.org/content/45/8/1293.abstract
AB We compared the contributions of the labeled tracers 11C-methionine (Met) and 18F-FDG for PET-guided stereotactic biopsy of brain gliomas. Methods: In 32 patients with glioma, stereotactic Met PET and 18F-FDG PET were integrated in the planning of stereotactic brain biopsy. PET images were analyzed to determine which tracer offered the best information for target definition. The stereotactic coregistration of PET images allowed accurate comparison of the level, distribution, and extent of uptake for both tracers according to tumor location and grade. Results: A histologic diagnosis was obtained for all patients. All gliomas had an area of abnormal Met uptake, and 27 showed abnormal 18F-FDG uptake. 18F-FDG was used for target selection when its uptake was higher in tumor than in gray matter (14 gliomas). Seven were in the basal ganglia or brain stem. Met was used for target selection when there was no 18F-FDG uptake or when 18F-FDG uptake was equivalent to that in the gray matter (18 gliomas). Thirteen were in the cortex. Sixty-one of the 70 stereotactic trajectories obtained from the 32 patients were based on PET-defined targets and had an area of abnormal Met uptake. These 61 Met-positive trajectories always yielded a diagnosis of tumor. All nondiagnostic trajectories (n = 9) were obtained in areas with no increased uptake of Met. In all patients with increased uptake of both tracers, the focus of highest Met uptake corresponded to the focus of highest 18F-FDG uptake. However, the extent of uptake of both tracers was variable. Conclusion: Distributions of highest Met and 18F-FDG uptake are similar in brain gliomas. Because Met provides a more sensitive signal, it is the molecule of choice for single-tracer PET-guided neurosurgical procedures in gliomas.